Pathophysiology of Prediabetes, Diabetes, and Diabetic Remission in Cats.
Gostelow R, Hazuchova K.
Vet Clin North Am Small Anim Pract. 2023 May;53(3):511-529. doi: 10.1016/j.cvsm.2023.02.001. Epub 2023 Mar 8.
Acromegaly pathogenesis and treatment.
Melmed S.
J Clin Invest. 2009 Nov;119(11):3189-202. doi: 10.1172/JCI39375. Epub 2009 Nov 2.
Diabetes in Patients With Acromegaly.
Hannon AM, Thompson CJ, Sherlock M.
Curr Diab Rep. 2017 Feb;17(2):8. doi: 10.1007/s11892-017-0838-7.
Acromegaly is associated with high fibroblast growth factor-21 levels.
Yurekli BS, Kutbay NO, Aksit M, Suner A, Simsir IY, Seckiner S, Kocabas GU, Bozkaya G, Saygili F.
J Endocrinol Invest. 2019 Jan;42(1):53-60. doi: 10.1007/s40618-018-0885-1. Epub 2018 May 12.
Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
Fukuoka H, Takahashi Y, Iida K, Kudo T, Nishizawa H, Imanaka M, Takeno R, Iguchi G, Takahashi K, Okimura Y, Kaji H, Chihara K.
Horm Res. 2008;69(3):165-71. doi: 10.1159/000112590. Epub 2008 Jan 8.
Insulin Resistance in Patients With Acromegaly.
Vila G, Jørgensen JOL, Luger A, Stalla GK.
Front Endocrinol (Lausanne). 2019 Jul 30;10:509. doi: 10.3389/fendo.2019.00509. eCollection 2019.
In patients with controlled acromegaly, indices of glucose homeostasis correlate with IGF-1 levels rather than with type of treatment.
Decock A, Verroken C, Van de Velde F, Vilsbøll T, Holst JJ, T'Sjoen G, Lapauw B.
Clin Endocrinol (Oxf). 2021 Jul;95(1):65-73. doi: 10.1111/cen.14461. Epub 2021 Mar 29.
Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide.
Couture E, Bongard V, Maiza JC, Bennet A, Caron P.
Pituitary. 2012 Dec;15(4):518-25. doi: 10.1007/s11102-011-0361-9.
Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population.
Rosario PW.
Pituitary. 2011 Sep;14(3):217-21. doi: 10.1007/s11102-010-0281-0.
Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved.
Kinoshita Y, Fujii H, Takeshita A, Taguchi M, Miyakawa M, Oyama K, Yamada S, Takeuchi Y.
Eur J Endocrinol. 2011 Apr;164(4):467-73. doi: 10.1530/EJE-10-1096. Epub 2011 Feb 1.
